Treatment of Pediatric Migraine

被引:22
|
作者
O'Brien, Hope L. [1 ,2 ]
Kabbouche, Marielle A. [1 ,2 ]
Kacperski, Joanne [1 ,2 ]
Hershey, Andrew D. [1 ,2 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA
关键词
Pediatric migraine; Primary headache; Treatment; NSAIDs; Triptans; Dopamine antagonists; DHE; Nutraceuticals; Chronic migraine; DOUBLE-BLIND; CHILDHOOD MIGRAINE; EMERGENCY-DEPARTMENT; PHARMACOLOGICAL-TREATMENT; SODIUM VALPROATE; DOSE RIBOFLAVIN; NASAL SPRAY; PLACEBO; CHILDREN; PROPHYLAXIS;
D O I
10.1007/s11940-014-0326-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The diagnosis of migraine in the pediatric population is increasing as providers are becoming more familiar with recognizing the condition. Over-the-counter and migraine-specific treatment, once considered off-label, have proven to be effective, especially if given at the early onset of head pain. Mild to severe cases of migraine should be treated with nonsteroidal anti-inflammatory drugs (NSAIDs), with triptans used alone or in combination in moderate to severe headaches unresponsive to over-the-counter therapy. Rescue medication including dihydroergotamine (DHE), a potent vasoconstrictor should be used for intractable migraines and is preferred in the hospital setting. Anti-emetics that have anti-dopaminergic properties can be helpful in patients with associated symptoms of nausea and vomiting along with headache, especially when used in combination therapy. Preventative treatment should be initiated early in patients with frequent headaches to improve headache outcomes and quality of life. Patients and families should be educated on non-pharmacologic management, such as lifestyle modification and avoidance of triggers, that can prevent progression and worsening of migraine.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 50 条
  • [41] Newly Approved Agents for the Treatment and Prevention of Pediatric Migraine
    Kacperski, Joanne
    Hershey, Andrew D.
    CNS DRUGS, 2016, 30 (09) : 837 - 844
  • [42] The acute and preventative treatment of episodic migraine
    Miller, Sarah
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2012, 15 : 33 - 39
  • [43] Topiramate for Treatment in Patients With Migraine and Epilepsy
    Spritzer, Scott D.
    Bravo, Thomas P.
    Drazkowski, Joseph F.
    HEADACHE, 2016, 56 (06): : 1081 - 1085
  • [44] Effects and side effects of migraine prophylaxis in children
    Tekin, Hande
    Edem, Pinar
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [45] Headache in the Pediatric Population: Focus on Migraine
    Irwin, Samantha L.
    Greene, Kaitlin A.
    Pavitt, Sara J.
    Ross, Alexandra C.
    SEMINARS IN NEUROLOGY, 2022, 42 (04) : 479 - 488
  • [46] Topiramate for Migraine Prophylaxis in Pediatric Patients
    Deaton, Tamara L.
    Mauro, Laurie S.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (05) : 638 - 643
  • [47] Effectiveness of riboflavin in pediatric migraine prevention
    Sherwood, Michelle
    Goldman, Ran D.
    CANADIAN FAMILY PHYSICIAN, 2014, 60 (03) : 244 - 246
  • [48] Factors Associated with Favorable Outcome of Topiramate Migraine Prophylaxis in Pediatric Patients
    Yoo, Il Han
    Kim, WooJoong
    Kim, Hunmin
    Lim, Byung Chan
    Hwang, Hee
    Chae, Jong-Hee
    Choi, Jieun
    Kim, Ki Joong
    JOURNAL OF CLINICAL NEUROLOGY, 2017, 13 (03): : 281 - 286
  • [49] The pharmacological treatment of migraine in children and adolescents: an overview
    Toldo, Irene
    De Carlo, Debora
    Bolzonella, Barbara
    Sartori, Stefano
    Battistella, Pier Antonio
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (09) : 1133 - 1142
  • [50] Drugs for the acute treatment of migraine in children and adolescents
    Faber, Alexandra J.
    Lagman-Bartolome, Ana Marissa
    Rajapakse, Thilinie
    PAEDIATRICS & CHILD HEALTH, 2017, 22 (08) : 454 - 458